Founded in 2003, Cure Leukaemia works with the sole aim of eradicating blood cancer across the world within a generation by funding the Trials Acceleration Programme (TAP). By funding the Trials Acceleration Programme, Cure Leukaemia enables the accelerated setup, recruitment to and delivery of pioneering blood cancer clinical trials connecting patients with potentially life-saving treatments not currently available and hastening global progress in finding a cure.